Medial septum differentially regulates dopamine neuron activity in the rat ventral tegmental area and substantia nigra via distinct pathways

The medial septum (MS) impacts hippocampal activity and the hippocampus, in turn, regulates midbrain dopamine (DA) neuron activity. However, it remains to be determined how MS activation impacts midbrain DA activity. This question was addressed by infusing NMDA (0.75 µg/0.2 µL) into the medial septu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychopharmacology (New York, N.Y.) N.Y.), 2018-09, Vol.43 (10), p.2093-2100
Hauptverfasser: Bortz, David M, Grace, Anthony A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2100
container_issue 10
container_start_page 2093
container_title Neuropsychopharmacology (New York, N.Y.)
container_volume 43
creator Bortz, David M
Grace, Anthony A
description The medial septum (MS) impacts hippocampal activity and the hippocampus, in turn, regulates midbrain dopamine (DA) neuron activity. However, it remains to be determined how MS activation impacts midbrain DA activity. This question was addressed by infusing NMDA (0.75 µg/0.2 µL) into the medial septum of anesthetized male Sprague-Dawley rats and recording dopamine neuron activity in the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc). MS activation increased (71%) the number of spontaneously active DA neurons in the VTA, and decreased (40%) the number of active DA neurons in the SNc. Effects in both the VTA and SNc required the ventral subiculum, but were differentially dependent on cholinergic and GABAergic mechanisms within the vSub and rostral and caudal subregions of the ventral pallidum, respectively. MS activation also decreased amphetamine-induced locomotor behavior, which was dependent on GABAergic inputs to the hippocampus. These findings demonstrate that the MS differentially regulates meso-striatal DA transmission via distinct pathways.
doi_str_mv 10.1038/s41386-018-0048-2
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6098086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2090564632</sourcerecordid><originalsourceid>FETCH-LOGICAL-p191t-af7689490404f248abf6c5c2e11eec51b23b032a0f24ecfa96a3fecbd3c379c73</originalsourceid><addsrcrecordid>eNpVkNtu1DAQhi1ERZfCA3CDLHEdGB_itW-QUMVJatUbkHoXTZzJrquNE2xn0b4DD12jFgRX82v-mW8OjL0S8FaAsu-yFsqaBoRtALRt5BO2EVsNjVH69inbgHWqEUrdnrPnOd8BiHZr7DN2Lp1ptTSwYb-uaQh44JmWsk58CONIiWKpucOJJ9qtByyU-TAvOIVIPNKa5sjRl3AM5cRD5GVPPGHhx9qXKqvQbqqyKkyEHOPA89rngr-xPIZdQn6sagi5hOgLX7Dsf-Ipv2BnIx4yvXyMF-z7p4_fLr80Vzefv15-uGoW4URpcKxXOO1Agx6lttiPxrdekhBEvhW9VD0oiVBN8iM6g2ok3w_Kq63zW3XB3j9wl7WfaPAPe3dLChOmUzdj6P53Yth3u_nYGXAWrKmAN4-ANP9YKZfubl5TrDt3Ehy0Rhsla9Xrf8f85f_5vroHX9eM7A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2090564632</pqid></control><display><type>article</type><title>Medial septum differentially regulates dopamine neuron activity in the rat ventral tegmental area and substantia nigra via distinct pathways</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Bortz, David M ; Grace, Anthony A</creator><creatorcontrib>Bortz, David M ; Grace, Anthony A</creatorcontrib><description>The medial septum (MS) impacts hippocampal activity and the hippocampus, in turn, regulates midbrain dopamine (DA) neuron activity. However, it remains to be determined how MS activation impacts midbrain DA activity. This question was addressed by infusing NMDA (0.75 µg/0.2 µL) into the medial septum of anesthetized male Sprague-Dawley rats and recording dopamine neuron activity in the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc). MS activation increased (71%) the number of spontaneously active DA neurons in the VTA, and decreased (40%) the number of active DA neurons in the SNc. Effects in both the VTA and SNc required the ventral subiculum, but were differentially dependent on cholinergic and GABAergic mechanisms within the vSub and rostral and caudal subregions of the ventral pallidum, respectively. MS activation also decreased amphetamine-induced locomotor behavior, which was dependent on GABAergic inputs to the hippocampus. These findings demonstrate that the MS differentially regulates meso-striatal DA transmission via distinct pathways.</description><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>DOI: 10.1038/s41386-018-0048-2</identifier><identifier>PMID: 29654260</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Activation ; Amphetamines ; Dopamine ; Hippocampus ; Mesencephalon ; N-Methyl-D-aspartic acid ; Neostriatum ; Neurons ; Pallidum (ventral) ; Rodents ; Septum ; Subiculum ; Substantia nigra ; Ventral tegmentum ; γ-Aminobutyric acid</subject><ispartof>Neuropsychopharmacology (New York, N.Y.), 2018-09, Vol.43 (10), p.2093-2100</ispartof><rights>Copyright Nature Publishing Group Sep 2018</rights><rights>American College of Neuropsychopharmacology 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-1864-5504</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098086/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098086/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29654260$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bortz, David M</creatorcontrib><creatorcontrib>Grace, Anthony A</creatorcontrib><title>Medial septum differentially regulates dopamine neuron activity in the rat ventral tegmental area and substantia nigra via distinct pathways</title><title>Neuropsychopharmacology (New York, N.Y.)</title><addtitle>Neuropsychopharmacology</addtitle><description>The medial septum (MS) impacts hippocampal activity and the hippocampus, in turn, regulates midbrain dopamine (DA) neuron activity. However, it remains to be determined how MS activation impacts midbrain DA activity. This question was addressed by infusing NMDA (0.75 µg/0.2 µL) into the medial septum of anesthetized male Sprague-Dawley rats and recording dopamine neuron activity in the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc). MS activation increased (71%) the number of spontaneously active DA neurons in the VTA, and decreased (40%) the number of active DA neurons in the SNc. Effects in both the VTA and SNc required the ventral subiculum, but were differentially dependent on cholinergic and GABAergic mechanisms within the vSub and rostral and caudal subregions of the ventral pallidum, respectively. MS activation also decreased amphetamine-induced locomotor behavior, which was dependent on GABAergic inputs to the hippocampus. These findings demonstrate that the MS differentially regulates meso-striatal DA transmission via distinct pathways.</description><subject>Activation</subject><subject>Amphetamines</subject><subject>Dopamine</subject><subject>Hippocampus</subject><subject>Mesencephalon</subject><subject>N-Methyl-D-aspartic acid</subject><subject>Neostriatum</subject><subject>Neurons</subject><subject>Pallidum (ventral)</subject><subject>Rodents</subject><subject>Septum</subject><subject>Subiculum</subject><subject>Substantia nigra</subject><subject>Ventral tegmentum</subject><subject>γ-Aminobutyric acid</subject><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpVkNtu1DAQhi1ERZfCA3CDLHEdGB_itW-QUMVJatUbkHoXTZzJrquNE2xn0b4DD12jFgRX82v-mW8OjL0S8FaAsu-yFsqaBoRtALRt5BO2EVsNjVH69inbgHWqEUrdnrPnOd8BiHZr7DN2Lp1ptTSwYb-uaQh44JmWsk58CONIiWKpucOJJ9qtByyU-TAvOIVIPNKa5sjRl3AM5cRD5GVPPGHhx9qXKqvQbqqyKkyEHOPA89rngr-xPIZdQn6sagi5hOgLX7Dsf-Ipv2BnIx4yvXyMF-z7p4_fLr80Vzefv15-uGoW4URpcKxXOO1Agx6lttiPxrdekhBEvhW9VD0oiVBN8iM6g2ok3w_Kq63zW3XB3j9wl7WfaPAPe3dLChOmUzdj6P53Yth3u_nYGXAWrKmAN4-ANP9YKZfubl5TrDt3Ehy0Rhsla9Xrf8f85f_5vroHX9eM7A</recordid><startdate>20180901</startdate><enddate>20180901</enddate><creator>Bortz, David M</creator><creator>Grace, Anthony A</creator><general>Nature Publishing Group</general><general>Springer International Publishing</general><scope>NPM</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1864-5504</orcidid></search><sort><creationdate>20180901</creationdate><title>Medial septum differentially regulates dopamine neuron activity in the rat ventral tegmental area and substantia nigra via distinct pathways</title><author>Bortz, David M ; Grace, Anthony A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p191t-af7689490404f248abf6c5c2e11eec51b23b032a0f24ecfa96a3fecbd3c379c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Activation</topic><topic>Amphetamines</topic><topic>Dopamine</topic><topic>Hippocampus</topic><topic>Mesencephalon</topic><topic>N-Methyl-D-aspartic acid</topic><topic>Neostriatum</topic><topic>Neurons</topic><topic>Pallidum (ventral)</topic><topic>Rodents</topic><topic>Septum</topic><topic>Subiculum</topic><topic>Substantia nigra</topic><topic>Ventral tegmentum</topic><topic>γ-Aminobutyric acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bortz, David M</creatorcontrib><creatorcontrib>Grace, Anthony A</creatorcontrib><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bortz, David M</au><au>Grace, Anthony A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medial septum differentially regulates dopamine neuron activity in the rat ventral tegmental area and substantia nigra via distinct pathways</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><addtitle>Neuropsychopharmacology</addtitle><date>2018-09-01</date><risdate>2018</risdate><volume>43</volume><issue>10</issue><spage>2093</spage><epage>2100</epage><pages>2093-2100</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><abstract>The medial septum (MS) impacts hippocampal activity and the hippocampus, in turn, regulates midbrain dopamine (DA) neuron activity. However, it remains to be determined how MS activation impacts midbrain DA activity. This question was addressed by infusing NMDA (0.75 µg/0.2 µL) into the medial septum of anesthetized male Sprague-Dawley rats and recording dopamine neuron activity in the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc). MS activation increased (71%) the number of spontaneously active DA neurons in the VTA, and decreased (40%) the number of active DA neurons in the SNc. Effects in both the VTA and SNc required the ventral subiculum, but were differentially dependent on cholinergic and GABAergic mechanisms within the vSub and rostral and caudal subregions of the ventral pallidum, respectively. MS activation also decreased amphetamine-induced locomotor behavior, which was dependent on GABAergic inputs to the hippocampus. These findings demonstrate that the MS differentially regulates meso-striatal DA transmission via distinct pathways.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>29654260</pmid><doi>10.1038/s41386-018-0048-2</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-1864-5504</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-133X
ispartof Neuropsychopharmacology (New York, N.Y.), 2018-09, Vol.43 (10), p.2093-2100
issn 0893-133X
1740-634X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6098086
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Activation
Amphetamines
Dopamine
Hippocampus
Mesencephalon
N-Methyl-D-aspartic acid
Neostriatum
Neurons
Pallidum (ventral)
Rodents
Septum
Subiculum
Substantia nigra
Ventral tegmentum
γ-Aminobutyric acid
title Medial septum differentially regulates dopamine neuron activity in the rat ventral tegmental area and substantia nigra via distinct pathways
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T11%3A19%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medial%20septum%20differentially%20regulates%20dopamine%20neuron%20activity%20in%20the%20rat%20ventral%20tegmental%20area%20and%20substantia%20nigra%20via%20distinct%20pathways&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=Bortz,%20David%20M&rft.date=2018-09-01&rft.volume=43&rft.issue=10&rft.spage=2093&rft.epage=2100&rft.pages=2093-2100&rft.issn=0893-133X&rft.eissn=1740-634X&rft_id=info:doi/10.1038/s41386-018-0048-2&rft_dat=%3Cproquest_pubme%3E2090564632%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2090564632&rft_id=info:pmid/29654260&rfr_iscdi=true